During the past decade, Ontario Dialysis Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ontario Dialysis Center" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ontario Dialysis Center" are "Anemia" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Chronic Kidney Diseases" (1 trials) and "Chronic Renal Failure" (1 trials). Many other conditions were trialed in "Ontario Dialysis Center" in a lesser frequency.

Most popular intervention types in "Ontario Dialysis Center" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials), "Calcifediol Oral Capsule" (1 trials), "Epogen (Amgen)" (1 trials), "HX575 epoetin alfa" (1 trials) and "Placebo oral capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ontario Dialysis Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ontario Dialysis Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ontario Dialysis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ontario Dialysis Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".